Ixensor Co

Ixensor Co CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Ixensor Co (6734.TWO) as of Nov 5, 2026 is -1.02 %. In the previous year, CapEx to Operating Cash Flow Ratio was -2.65 % — a change of -61.29% (higher).

CapEx/OCF

-1.02 %

YoY

-61.29%

Last updated:

CapEx to Operating Cash Flow Ratio of Ixensor Co is 2025 -1.02 % . CapEx to Operating Cash Flow Ratio of Ixensor Co was 2024 -2.65 % . It decreases by -61.29% higher compared to the previous year.

The Ixensor Co CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
-4.47 TWD
Jan 1, 2019
-1.59 TWD
Jan 1, 2020
-3.24 TWD
Jan 1, 2021
-2.19 TWD
Jan 1, 2022
9.18 TWD
Jan 1, 2023
-3.79 TWD
Jan 1, 2024
-2.65 TWD
Jan 1, 2025
-1.02 TWD
The Ixensor Co CapEx/OCF history
YEARCapEx/OCFYoY
-1.02 %-61.29%
-2.65 %-30.20%
-3.79 %-141.30%
9.18 %-518.74%
-2.19 %-32.26%
-3.24 %+103.50%
-1.59 %-64.45%
-4.47 %-66.20%
-13.23 %+38.01%
-9.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ixensor Co Stock analysis

What does Ixensor Co do? iXensor Co., Ltd. generates revenue through its PixoTest Blood Glucose Monitoring System and ovulation detection system, targeting individuals managing diabetes and reproductive health. The company's technology platform measures biochemical parameters including blood sugar, luteinizing hormone, and cholesterol, providing data for diabetes management services. Its integrated medical device solutions serve customers seeking self-monitoring tools for chronic conditions and fertility tracking. The firm's products are designed for direct consumer use, with the PixoTest system offering blood glucose monitoring and the ovulation detection system supporting female hormone cycle management. These solutions leverage the company's platform to deliver personalized health insights without requiring third-party partnerships. The target segments include patients with diabetes and individuals tracking fertility cycles through biochemical monitoring. Ixensor Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ixensor Co stock

CapEx to Operating Cash Flow Ratio of Ixensor Co is -1.02 % in 2025.

CapEx to Operating Cash Flow Ratio of Ixensor Co changed from -2.65 % to -1.02 %, representing a -61.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Ixensor Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Ixensor Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ixensor Co

All Key Metrics — Ixensor Co